Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | CEP70 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CEP70 mRNA | CTD | PMID:22079256 | (1->4)-beta-D-glucan | multiple interactions | ISO | Cep70 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CEP70 mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | decreases expression | ISO | Cep70 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of CEP70 mRNA | CTD | PMID:22206623 | 1,3-dinitrobenzene | decreases expression | EXP | | 6480464 | 3-dinitrobenzene results in decreased expression of CEP70 mRNA | CTD | PMID:21983209 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CEP70 mRNA | CTD | PMID:26232522 | 3-methylcholanthrene | multiple interactions | ISO | CEP70 (Homo sapiens) | 6480464 | Methylcholanthrene promotes the reaction [AHR protein binds to CEP70 promoter] | CTD | PMID:20348232 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Cep70 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of CEP70 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of CEP70 mRNA | CTD | PMID:24780913 | aflatoxin B1 | increases expression | ISO | Cep70 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of CEP70 mRNA | CTD | PMID:19770486 | aflatoxin B1 | decreases expression | ISO | CEP70 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of CEP70 mRNA | CTD | PMID:22100608 | aflatoxin M1 | decreases expression | ISO | CEP70 (Homo sapiens) | 6480464 | Aflatoxin M1 results in decreased expression of CEP70 mRNA | CTD | PMID:30928695 | all-trans-retinoic acid | increases expression | ISO | CEP70 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of CEP70 mRNA | CTD | PMID:21934132 | all-trans-retinoic acid | decreases expression | ISO | CEP70 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of CEP70 mRNA | CTD | PMID:33167477 | aristolochic acid A | decreases expression | ISO | CEP70 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of CEP70 mRNA | CTD | PMID:33212167 | arsenous acid | increases expression | ISO | CEP70 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of CEP70 mRNA | CTD | PMID:20458559 | atrazine | decreases expression | ISO | CEP70 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of CEP70 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | decreases expression | ISO | CEP70 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of CEP70 mRNA | CTD | PMID:21632981 and PMID:26238291 | benzo[a]pyrene | affects methylation | ISO | CEP70 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of CEP70 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | CEP70 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:20018196 | bisphenol A | increases expression | ISO | Cep70 (Mus musculus) | 6480464 | bisphenol A results in increased expression of CEP70 mRNA | CTD | PMID:26063408 | bisphenol A | decreases expression | ISO | CEP70 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of CEP70 protein | CTD | PMID:33376534 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CEP70 mRNA | CTD | PMID:34947998 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of CEP70 gene | CTD | PMID:28505145 | carbon nanotube | decreases expression | ISO | Cep70 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | CGP 52608 | multiple interactions | ISO | CEP70 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to CEP70 gene] | CTD | PMID:28238834 | chlorpyrifos | decreases expression | ISO | Cep70 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of CEP70 mRNA | CTD | PMID:37019170 | clorgyline | increases expression | ISO | CEP70 (Homo sapiens) | 6480464 | Clorgyline results in increased expression of CEP70 mRNA | CTD | PMID:19691856 | copper(II) sulfate | decreases expression | ISO | CEP70 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of CEP70 mRNA | CTD | PMID:19549813 | cordycepin | increases expression | ISO | Cep70 (Mus musculus) | 6480464 | cordycepin results in increased expression of CEP70 mRNA | CTD | PMID:32042022 | crocidolite asbestos | decreases expression | ISO | Cep70 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of CEP70 mRNA | CTD | PMID:29279043 | cyclosporin A | decreases expression | ISO | CEP70 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of CEP70 mRNA | CTD | PMID:25562108 | diarsenic trioxide | increases expression | ISO | CEP70 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of CEP70 mRNA | CTD | PMID:20458559 | dicrotophos | decreases expression | ISO | CEP70 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of CEP70 mRNA | CTD | PMID:28302478 | dioxygen | multiple interactions | ISO | Cep70 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CEP70 mRNA | CTD | PMID:30529165 | dorsomorphin | multiple interactions | ISO | CEP70 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | affects expression | ISO | CEP70 (Homo sapiens) | 6480464 | Doxorubicin affects the expression of CEP70 mRNA | CTD | PMID:29803840 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of CEP70 mRNA | CTD | PMID:29391264 | entinostat | multiple interactions | ISO | CEP70 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CEP70 mRNA | CTD | PMID:27188386 | entinostat | decreases expression | ISO | CEP70 (Homo sapiens) | 6480464 | entinostat results in decreased expression of CEP70 mRNA | CTD | PMID:26272509 | epoxiconazole | increases expression | ISO | Cep70 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of CEP70 mRNA | CTD | PMID:35436446 | furan | increases expression | EXP | | 6480464 | furan results in increased expression of CEP70 mRNA | CTD | PMID:25539665 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of CEP70 mRNA | CTD | PMID:33387578 | inulin | multiple interactions | ISO | Cep70 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CEP70 mRNA | CTD | PMID:36331819 | ketamine | decreases expression | EXP | | 6480464 | Ketamine results in decreased expression of CEP70 mRNA | CTD | PMID:20080153 | nickel atom | decreases expression | ISO | CEP70 (Homo sapiens) | 6480464 | Nickel results in decreased expression of CEP70 mRNA | CTD | PMID:24768652 and PMID:25583101 | oxaliplatin | decreases expression | EXP | | 6480464 | oxaliplatin results in decreased expression of CEP70 mRNA | CTD | PMID:25729387 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of CEP70 mRNA | CTD | PMID:25729387 | paracetamol | increases expression | ISO | CEP70 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of CEP70 mRNA | CTD | PMID:22230336 and PMID:26690555 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CEP70 mRNA | CTD | PMID:33387578 | perfluorooctane-1-sulfonic acid | decreases expression | ISO | CEP70 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of CEP70 mRNA | CTD | PMID:27153767 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Cep70 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CEP70 mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CEP70 mRNA | CTD | PMID:36331819 | phenobarbital | affects expression | ISO | Cep70 (Mus musculus) | 6480464 | Phenobarbital affects the expression of CEP70 mRNA | CTD | PMID:19136022 | phenylmercury acetate | decreases expression | ISO | CEP70 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of CEP70 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | CEP70 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CEP70 mRNA | CTD | PMID:27188386 | pirinixic acid | affects expression | ISO | Cep70 (Mus musculus) | 6480464 | pirinixic acid affects the expression of CEP70 mRNA | CTD | PMID:19136022 | pirinixic acid | increases expression | ISO | Cep70 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of CEP70 mRNA | CTD | PMID:23811191 | potassium chromate | decreases expression | ISO | CEP70 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of CEP70 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | CEP70 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CEP70 mRNA | CTD | PMID:22079256 | potassium dichromate | decreases expression | ISO | Cep70 (Mus musculus) | 6480464 | Potassium Dichromate results in decreased expression of CEP70 mRNA | CTD | PMID:23608068 | quercetin | decreases expression | ISO | CEP70 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of CEP70 mRNA | CTD | PMID:21632981 | SB 431542 | multiple interactions | ISO | CEP70 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silver atom | increases expression | ISO | Cep70 (Mus musculus) | 6480464 | Silver results in increased expression of CEP70 mRNA | CTD | PMID:27131904 | silver(0) | increases expression | ISO | Cep70 (Mus musculus) | 6480464 | Silver results in increased expression of CEP70 mRNA | CTD | PMID:27131904 | sodium arsenite | affects expression | ISO | CEP70 (Homo sapiens) | 6480464 | sodium arsenite affects the expression of CEP70 mRNA | CTD | PMID:34032870 | sodium arsenite | increases expression | ISO | Cep70 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of CEP70 mRNA | CTD | PMID:37682722 | sulforaphane | decreases expression | ISO | CEP70 (Homo sapiens) | 6480464 | sulforaphane results in decreased expression of CEP70 mRNA | CTD | PMID:26833863 | sunitinib | decreases expression | ISO | CEP70 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of CEP70 mRNA | CTD | PMID:31533062 | tetraphene | increases expression | ISO | Cep70 (Mus musculus) | 6480464 | benz(a)anthracene results in increased expression of CEP70 mRNA | CTD | PMID:26377693 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of CEP70 mRNA | CTD | PMID:22659510 and PMID:23411599 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of CEP70 mRNA | CTD | PMID:25729387 | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of CEP70 mRNA | CTD | PMID:25729387 | trichostatin A | decreases expression | ISO | CEP70 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of CEP70 mRNA | CTD | PMID:24935251 and PMID:26272509 | trichostatin A | increases expression | ISO | CEP70 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of CEP70 mRNA | CTD | PMID:27188386 | trichostatin A | multiple interactions | ISO | CEP70 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CEP70 mRNA | CTD | PMID:27188386 | urethane | increases expression | ISO | CEP70 (Homo sapiens) | 6480464 | Urethane results in increased expression of CEP70 mRNA | CTD | PMID:28818685 | valproic acid | decreases methylation | ISO | CEP70 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of CEP70 gene | CTD | PMID:29154799 | valproic acid | affects expression | ISO | CEP70 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of CEP70 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | CEP70 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of CEP70 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | ISO | CEP70 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CEP70 mRNA | CTD | PMID:27188386 | vorinostat | increases expression | ISO | CEP70 (Homo sapiens) | 6480464 | vorinostat results in increased expression of CEP70 mRNA | CTD | PMID:27188386 | |